Mini-Mental state examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 10, 2013, Pages

  Arevalo Rodriguez, Ingrid ^a   Smailagic, Nadja ^b   Ciapponi, Agustín ^c   Sanchez Perez, Erick ^d   Giannakou, Antri ^e   Roquéi Figuls, Marta ^f   Pedraza, Olga L ^d   Bonfill Cosp, Xavier ^g   Cullum, Sarah ^h  

^a HOSPITAL DE SAN JOSÉ   (Colombia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c INSTITUTE FOR CLINICAL EFFECTIVENESS AND HEALTH POLICY   (Argentina)

^d Hospital Universitario de San José   (Colombia)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFUSE LEWY BODY DISEASE; FRONTOTEMPORAL DEMENTIA; GOLD STANDARD; HUMAN; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

EID: 84962834864     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010783     Document Type: Article

References (57)

1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al.The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011; Vol. 7, issue 3:270-9.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington DC: American Psychiatric Association, 1994.
3. Arevalo-Rodriguez I, Pedraza OL, Rodríguez A, Sánchez E, Gich I, Solà I, et al.Alzheimer and CloseCurlyQuote;s disease dementia guidelines for diagnostic testing: a systematic review. American Journal of Alzheimer's Disease and Other Dementias 2013;28(2):111-9. [PUBMED: 23288575]
4. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD005593; PUBMED: 16437532]
5. Bleecker ML, Bolla-Wilson K, Kawas C, Agnew J. Age-specific norms for the Mini-Mental State Exam. Neurology 1988;38(10):1565-8. [PUBMED: 3419600]
6. Boustani M, Peterson B, Hanson L, Harris R, Lohr KN. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2003;138(11):927-37. [PUBMED: 12779304]
7. Brayne C, Calloway P. The association of education and socioeconomic status with the Mini Mental State Examination and the clinical diagnosis of dementia in elderly people. Age and Ageing 1990;19(2):91-6. [PUBMED: 2337015]
8. Brayne C, Stephan BC, Matthews FE. A European perspective on population studies of dementia. Alzheimer's & Dementia 2011;7(1):3-9. [PUBMED: 21255739]
9. Bruscoli M, Lovestone S. Is MCI really just early dementia? A systematic review of conversion studies. International Psychogeriatrics 2004;16(2):129-40. [PUBMED: 15318760]
10. Clare L, Woods RT, Moniz Cook ED, Orrell M, Spector A. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003260; PUBMED: 14583963]
11. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. Journal of the American Medical Association 1993;269(18):2386-91. [PUBMED: 8479064]
12. Davis Daniel HJ, Creavin Sam T, Noel-Storr A, Quinn Terry J, Smailagic N, Hyde C, et al.Neuropsychological tests for the diagnosis of Alzheimer and CloseCurlyQuote;s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies. Cochrane Database of Systematic Reviews 2013, Issue 3. [DOI: 10.1002/14651858.CD010460;: CD010460]
13. de Silva V, Hanwella R. Why are we copyrighting science?. BMJ 2010;341:c4738. [PUBMED: 20847026]
14. Diniz BS, Yassuda MS, Nunes PV, Radanovic M, Forlenza OV. Mini-Mental State Examination performance in mild cognitive impairment subtypes. International Psychogeriatrics 2007;19(4):647-56. [PUBMED: 17502007]
15. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, et al.Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurology 2010;9(11):1118-27. [PUBMED: 20934914]
16. Farina N, Isaac MGEKN, Clark Annalie R, Rusted J, Tabet N. Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD002854.pub3;: CD002854]
17. Feldman HH, Jacova C, Robillard A, Garcia A, Chow T, Borrie M, et al.Diagnosis and treatment of dementia: 2. Diagnosis. Canadian Medical Association Journal 2008;178(7):825-36. [PUBMED: 18362376]
18. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al.Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366(9503):2112-7. [PUBMED: 16360788]
19. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12(3):189-98. [PUBMED: 1202204]
20. Glanville J, Cikalo M, Crawford F, Dozier M, McIntosh H. Handsearching did not yield additional unique FDG-PET diagnostic test accuracy studies compared with electronic searches: a preliminary investigation. Research Synthesis Methods 2012;3(3):202-13. [DOI: 10.1002/jrsm.1046]
21. Goetz CG, Emre M, Dubois B. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Annals of Neurology 2008;64 Suppl 2:S81-92. [PUBMED: 19127578]
22. Hort J, O'Brien JT, Gainotti G, Pirttila T, Popescu BO, Rektorova I, et al.EFNS guidelines for the diagnosis and management of Alzheimer's disease. European Journal of Neurology 2010;17(10):1236-48. [PUBMED: 20831773]
23. Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, et al.Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7(3):257-62. [PUBMED: 21514247]
24. Kulisevsky J, Pagonabarraga J. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Movement Disorders 2009;24(8):1103-10. [PUBMED: 19353727]
25. Leeflang MM, Moons KG, Reitsma JB, Zwinderman AH. Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. Clinical Chemistry 2008;54(4):729-37. [PUBMED: 18258670]
26. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. Journal of Neurology, Neurosurgery and Psychiatry 1994;57:416-8. [PUBMED: 8163988]
27. Matthews FE, Stephan BC, McKeith IG, Bond J, Brayne C. Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?. Journal of the American Geriatrics Society 2008;56(8):1424-33. [PUBMED: 18662209]
28. Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Medicine 2009;6(11):e1000180. [PUBMED: 19901977]
29. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al.Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47(5):1113-24. [PUBMED: 8909416]
30. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al.Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65(12):1863-72. [PUBMED: 16237129]
31. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34(7):939-44. [PUBMED: 6610841]
32. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al.The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7(3):263-9. [PUBMED: 21514250]
33. McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD003154.pub5; PUBMED: 16625572]
34. Mitchell AJ, Shiri-Feshki M. Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis. Journal of Neurology, Neurosurgery, and Psychiatry 2008;79(12):1386-91.
35. Mitchell AJ. A meta-analysis of the accuracy of the Mini-Mental State Examination in the detection of dementia and mild cognitive impairment. Journal of Psychiatric Research 2009;43(4):411-31. [PUBMED: 18579155]
36. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43(11):2412-4. [PUBMED: 8232972]
37. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357(0140-6736 (Print)):169-75. [PUBMED: 11213093]
38. Nieuwenhuis-Mark RE. The death knoll for the MMSE: has it outlived its purpose?. Journal of Geriatric Psychiatry and Neurology 2010;23(3):151-7. [PUBMED: 20231732]
39. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology 1999;56(3):303-8. [PUBMED: 10190820]
40. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56(9):1133-42.
41. Petersen RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 2004;256(3):183-94. [PUBMED: 15324362]
42. Petersen RC. Clinical practice: mild cognitive impairment. The New England Journal of Medicine 2011;364(23):2227-34.
43. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al.Prevalence of cognitive impairment without dementia in the United States. Annals of Internal Medicine 2008;148(6):427-34.
44. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58(10):982-90. [PUBMED: 16168343]
45. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al.Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43(2):250-60. [PUBMED: 8094895]
46. Russ Tom C, Morling Joanne R. Cholinesterase inhibitors for mild cognitive impairment. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD009132.pub2;: CD009132]
47. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. New England Journal of Medicine 2009;360(22):2302-9. [PUBMED: 19474427]
48. Scheltens P, Rockwood K. How golden is the gold standard of neuropathology in dementia?. Alzheimer's & Dementia 2011;7(4):486-9. [PUBMED: 21784357]
49. Shiroky JS, Schipper HM, Bergman H, Chertkow H. Can you have dementia with an MMSE score of 30?. American Journal of Alzheimer's Disease and Other Dementias 2007;22(5):406-15. [PUBMED: 17959876]
50. Stephan BC, Matthews FE, McKeith IG, Bond J, Brayne C. Early cognitive change in the general population: how do different definitions work?. Journal of the American Geriatrics Society 2007;55(10):1534-40.
51. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. Journal of the American Geriatrics Society 1992;40(9):922-35. [PUBMED: 1512391]
52. Trenkle DL, Shankle WR, Azen SP. Detecting cognitive impairment in primary care: performance assessment of three screening instruments. Journal of Alzheimer's Disease 2007;11(3):323-35. [PUBMED: 17851183]
53. Whiting P, Westwood M, Beynon R, Burke M, Sterne JA, Glanville J. Inclusion of methodological filters in searches for diagnostic test accuracy studies misses relevant studies. Journal of Clinical Epidemiology 2011;64(6):602-7. [PUBMED: 21075596]
54. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al.QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529-36. [PUBMED: 22007046]
55. Wimo A, Winblad B, Jonsson L. The worldwide societal costs of dementia: estimates for 2009. Alzheimer's & Dementia 2010;6(2):98-103. [PUBMED: 20298969 ]
56. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al.Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine 2004;256(3):240-6. [PUBMED: 15324367]
57. Yue J, Dong BR, Lin X, Yang M, Wu HM, Wu T. Huperzine A for mild cognitive impairment. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD008827.pub2;: CD008827]